Thomas G Auchincloss Concert Pharmaceuticals, Inc. (CNCE) insider trading activity

CNCE Quotes by TradingView

Thomas G Auchincloss is Director of CONCERT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of CNCE, which is worth approximately $0. The most recent transaction as insider was on Mar 06, 2023, when has been sold 17,625 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Thomas G Auchincloss Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
17,625 Reduced 100.0%
0 Common Stock
Mar 06 2023
SELL
Sale (or disposition) back to the issuer
-
16,400 Reduced 100.0%
0 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
16,400 Added 32.52%
34,025 Common Stock
Jun 06 2022
BUY
Open market or private purchase
$28,500 $4.75 p/Share
6,000 Added 25.4%
17,625 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
5,125 Added 30.6%
11,625 Common Stock
TGA

Thomas G Auchincloss

Director
Lexington, MA

Track Institutional and Insider Activities on CNCE

Follow CONCERT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNCE shares.

Notify only if

Insider Trading

Get notified when an Concert Pharmaceuticals, Inc. insider buys or sells CNCE shares.

Notify only if

News

Receive news related to CONCERT PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNCE